Skip to main content
TGTX logo

TGTX · Tg Therapeutics, Inc.

Track TGTX — free
$48.74 +0.80 (+1.67%) At close · Aug 14
Market Cap
$7.46B
Shares
153.07M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-08-03 TG Therapeutics Q2 2026 Financial Results and Business Update Event
2026-06-09 Goldman Sachs 47th Annual Global Healthcare Conference Conference
2026-06-03 Jefferies Global Healthcare Conference 2026 Conference
2026-05-06 Earnings conference call (announced in 8-K) Earnings call
2026-02-26 Earnings conference call (announced in 8-K) Earnings call
2026-01-13 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-02 8th Annual Evercore Healthcare Conference Conference
2025-11-12 TD Cowen Immunology & Inflammation Summit Event
2025-11-03 TG Therapeutics Q3 2025 - Financial Results and Business Update Event
2025-09-08 H.C. Wainwright 27th Annual Global Investment Conference Conference
2025-09-03 Cantor Global Healthcare Conference 2025 Conference
2025-08-04 TG Therapeutics Q2 2025 - Financial Results and Business Update Event
2025-06-10 Goldman Sachs 46th Annual Global Healthcare Conference 2025 Conference
2025-06-04 Jefferies Global Healthcare Conference 2025 Conference
2025-05-05 TG Therapeutics Q1 2025 - Financial Results and Business Update Event
2025-03-03 TG Therapeutics Q4 and Full Year 2024 - Financial Results and Business Update Event
2025-01-14 43rd Annual J.P.Morgan Healthcare Conference Conference
2024-12-03 7th Annual Evercore HealthCONx Conference Conference
2024-11-04 TG Therapeutics Q3 2024 Financial Results and Business Update Event
2024-08-06 TG Therapeutics Q2 2024 Financial Results and Business Update Event
2024-06-11 Goldman Sachs 45th Annual Global Healthcare Conference Conference
2024-06-05 Jefferies Global Healthcare Conference 2024 Conference
2024-05-01 TG Therapeutics Q1 2024 Financial Results and Business Update Event
2024-02-28 Q4 and Year-End 2023 Financial Results and Business Update Event
2024-01-10 42nd Annual J.P.Morgan Healthcare Conference Conference

Source: https://www.tgtherapeutics.com/investors-media/

Key facts CIK 1001316 CUSIP 88322Q108 13F (30d) 395 filings 391 filers Visit website Investor relations